The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
me change notification emails
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
Description of Modification
Due to severe weather experienced during the past week, the closing deadline for the pre-application is extended.
Modification to Previous
Funding Opportunity Number:
May 31, 2012
Jul 03, 2012
Original Closing Date for Applications:
Oct 01, 2012
Current Closing Date for Applications:
Oct 01, 2012
Oct 31, 2012
Funding Instrument Type:
Category of Funding Activity:
Science and Technology and other Research and Development
Expected Number of Awards:
Estimated Total Program Funding:
Military Medical Research and Development
Cost Sharing or Matching Requirement:
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Dept. of the Army -- USAMRAA
The Translational Research Award (TRA) mechanism was first offered as the Translational Research Partnership Award (TRPA) in FY09. Thirty-one TRPA applications were received, and 9 were recommended for funding. NEW for FY12: The award mechanism has been modified to support individual investigators, and is no longer limited to multi-institutional, multidisciplinary partnerships among clinicians and basic scientists.
This award supports translational research that will accelerate the movement of promising ideas in spinal cord injury research into clinical applications. Observations that drive a research idea may be derived from a laboratory discovery, population-based studies, or a clinician’s first-hand knowledge of patients and anecdotal data. While the ultimate goal of translational research is to move an observation forward into clinical application, PIs should not view translational research as a one-way continuum from bench to bedside. The research plan must involve a reciprocal flow of ideas and information between basic and clinical science. Developmental pathways for translational research that may be useful for designing translational research studies for support under this mechanism may be found at (http://www.cancer.gov/aboutnci/trwg/Pathways-to-Clinical-Goals).
Applications must include preliminary data relevant to SCI and the proposed project.
Research involving human subjects and human anatomical substances is permitted; however, clinical trials are not allowed under this funding opportunity. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested with a human subject for a measurable outcome with respect to exploratory information, safety,
effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. For more information on clinical trials and clinical research, a Human Subject Resource Document is provided on the CDMRP eReceipt System at https://cdmrp.org/Program_Announcements_and_Forms/. Principal Investigators (PIs) wishing to apply for funding for a clinical trial should utilize the FY12 SCIRP Clinical Trial Award mechanism (Funding Opportunity Number: W81XWH-12-SCIRP-CTA).
Link to Additional Information
If you have difficulty accessing the full announcement
electronically, please contact:
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.